{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:49:58Z","timestamp":1784159398976,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.amjcard.2019.01.013","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T21:59:28Z","timestamp":1548453568000},"page":"1351-1357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-1797","authenticated-orcid":false,"given":"Nicolas","family":"Palaskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Daigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Banchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Bernard","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aung","family":"Naing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saamir A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Karimzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Mouhayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1177-8761","authenticated-orcid":false,"given":"Juan","family":"Lopez-Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Wamique","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-4579","authenticated-orcid":false,"given":"Cezar","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.01.013_bib0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/clc.4960110606","article-title":"Etiology and prognostic implications of a large pericardial effusion in men","volume":"11","author":"Colombo","year":"1988","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0002","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.md.0000199556.69588.8e","article-title":"Large symptomatic pericardial effusion as the presentation of unrecognized cancer: a study in 173 consecutive patients undergoing pericardiocentesis","volume":"85","author":"Ben-Horin","year":"2006","journal-title":"Medicine"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0003","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ijcard.2016.08.023","article-title":"Pericardial effusion with tamponade physiology induced by nivolumab","volume":"222","author":"Nesfeder","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000447053","article-title":"Nivolumab-induced pericardial tamponade: a case report and discussion","volume":"136","author":"Kushnir","year":"2017","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/CJI.0000000000000217","article-title":"Immune-mediated pericarditis with pericardial tamponade during nivolumab therapy","volume":"41","author":"de Almeida","year":"2018","journal-title":"J Immunother"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1078155216635853","article-title":"Late-onset pericardial tamponade, bilateral pleural effusions and recurrent immune monoarthritis induced by ipilimumab use for metastatic melanoma","volume":"23","author":"Dasanu","year":"2017","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0008","article-title":"Late onset ipilimumab-induced pericarditis and pericardial effusion: a rare but life threatening complication","volume":"2015","author":"Yun","year":"2015","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0009","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jtho.2017.03.012","article-title":"Pericardial tamponade caused by a hypersensitivity response to tuberculosis reactivation after anti-PD-1 treatment in a patient with advanced pulmonary adenocarcinoma","volume":"12","author":"Chu","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-018-0104-y","article-title":"Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature","volume":"7","author":"Shaheen","year":"2018","journal-title":"Exp Hematol & Oncol"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0011","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJM199912303412704","article-title":"Long-term follow-up of idiopathic chronic pericardial effusion","volume":"341","author":"Sagrist\u00e0-Sauleda","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0012","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.70.6.966","article-title":"Right ventricular and right atrial collapse in patients with cardiac tamponade\u2013a combined echocardiographic and hemodynamic study","volume":"70","author":"Singh","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0013","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0735-1097(88)80011-1","article-title":"Inferior vena cava plethora with blunted respiratory response: a sensitive echocardiography sign of cardiac tamponade","volume":"12","author":"Himelman","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0014","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0025-6196(12)65251-3","article-title":"Cardiac tamponade: characteristic doppler observations","volume":"64","author":"Burstow","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40425-017-0300-z","article-title":"Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group","volume":"5","author":"Puzanov","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0016","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40425-016-0185-2","article-title":"Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy- a report of two cases","volume":"4","author":"Kolla","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.amjcard.2019.01.013_bib0017","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00262-008-0642-y","article-title":"Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases","volume":"58","author":"Di Giacomo","year":"2009","journal-title":"Cancer Immunol Immunother"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919301055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919301055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T07:25:42Z","timestamp":1606202742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919301055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0002914919301055"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.01.013","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}